Neuroprotective effects of GSK-343 in an in vivo model of MPTP-induced nigrostriatal degeneration
Neuroprotective effects of GSK-343 in an in vivo model of MPTP-induced nigrostriatal degeneration
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Parkinson’s disease (PD) is characterized by the degeneration of dopaminergic nigrostriatal neurons, which causes disabling motor disorders. Scientific findings support the role of epigenetics mechanism in the development and progression of many neurodegenerative diseases, including PD. In this field, some studies highlighted an upregulation of Enh...
Alternative Titles
Full title
Neuroprotective effects of GSK-343 in an in vivo model of MPTP-induced nigrostriatal degeneration
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_8b1b3326f2bf410d923d895c5a431441
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8b1b3326f2bf410d923d895c5a431441
Other Identifiers
ISSN
1742-2094
E-ISSN
1742-2094
DOI
10.1186/s12974-023-02842-6
